Next PLC — Director's Dealing 2018

Oct 16, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2293E

Citadel Group

16 October 2018

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%

OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:	Citadel Group
(b) Owner or controller of interests and short positions              disclosed, if different from 1(a):      The naming of nominee or vehicle companies is      insufficient.  For a trust, the trustee(s), settlor and      beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant      securities this form relates:      Use a separate form for each offeror/offeree	NEX GROUP PLC
(d) If an exempt fund manager connected with an      offeror/offeree, state this and specify identity of      offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure	15 October, 2018
(f)  In addition to the company in 1(c) above, is the      discloser making disclosures in respect of any other      party to the offer? If it is a cash offer or possible cash offer, state "N/A"	CME GROUP INC

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:	Common Stock  ISIN  GB00BZ02MH16
	Interests		Short Positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:	0	0.00	4,303	0.00
(2) Cash-settled derivatives:	6,500,001	1.71	0	0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:	0	0.00	0	0.00
TOTAL:	6,500,001	1.71	4,303	0.00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security ISIN  GB00BZ02MH16	Purchase/sale	Number of securities	Price per unit
Common Stock	Purchase	510	10.43  GBP
Common Stock	Purchase	1,824	10.44  GBP
Common Stock	Purchase	17,497	10.45  GBP
Common Stock	Purchase	2,804	10.46  GBP
Common Stock	Purchase	65,977	10.47  GBP
Common Stock	Purchase	352	10.475  GBP
Common Stock	Purchase	19,727	10.48  GBP
Common Stock	Purchase	11,376	10.49  GBP
Common Stock	Purchase	21,354	10.5  GBP
Common Stock	Purchase	21,762	10.51  GBP
Common Stock	Purchase	19,394	10.52  GBP
Common Stock	Purchase	11,302	10.53  GBP
Common Stock	Purchase	3,493	10.54  GBP
Common Stock	Purchase	16,298	10.55  GBP
Common Stock	Purchase	166	10.555  GBP
Common Stock	Purchase	12,234	10.56  GBP
Common Stock	Purchase	1,460	10.565  GBP
Common Stock	Purchase	6,208	10.57  GBP
Common Stock	Purchase	856	10.58  GBP
Common Stock	Purchase	1,040	10.59  GBP
Common Stock	Purchase	188	10.6  GBP
Common Stock	Purchase	681	10.62  GBP
Common Stock	Purchase	490	10.63  GBP
Common Stock	Purchase	600	10.64  GBP
Common Stock	Sale	-786	10.25  GBP
Common Stock	Sale	-81	10.27  GBP
Common Stock	Sale	-2,142	10.29  GBP
Common Stock	Sale	-4,183	10.3  GBP
Common Stock	Sale	-2,611	10.31  GBP
Common Stock	Sale	-395	10.35  GBP
Common Stock	Sale	-1,500	10.36  GBP
Common Stock	Sale	-2,200	10.37  GBP
Common Stock	Sale	-1,900	10.38  GBP
Common Stock	Sale	-1,469	10.4  GBP
Common Stock	Sale	-2,253	10.4375  GBP
Common Stock	Sale	-14,001	10.44  GBP
Common Stock	Sale	-18,864	10.45  GBP
Common Stock	Sale	-14,057	10.46  GBP
Common Stock	Sale	-4,982	10.47  GBP
Common Stock	Sale	-14,283	10.48  GBP
Common Stock	Sale	-31,626	10.49  GBP
Common Stock	Sale	-788	10.495  GBP
Common Stock	Sale	-31,760	10.5  GBP
Common Stock	Sale	-17,487	10.51  GBP
Common Stock	Sale	-90	10.515  GBP
Common Stock	Sale	-16,258	10.52  GBP
Common Stock	Sale	-12,260	10.53  GBP
Common Stock	Sale	-3,883	10.54  GBP
Common Stock	Sale	-7,699	10.55  GBP
Common Stock	Sale	-665	10.56  GBP
Common Stock	Sale	-1,010	10.57  GBP
Common Stock	Sale	-1,219	10.58  GBP
Common Stock	Sale	-4,665	10.59  GBP

(b)        Cash-settled derivative transactions

Class of relevant security ISIN  GB00BZ02MH16	Product description e.g. CFD	Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position	Number of reference securities	Price per unit
Common Stock	CFD	Increasing long position	1,000,000	10.486708  GBP

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of relevant security	Product description e.g. call option	Writing, purchasing, selling, varying etc.	Number of securities to which option relates	Exercise price per unit	Type e.g. American, European etc.	Expiry date	Option money paid/ received per unit

(ii)        Exercise

Class of relevant security	Product description e.g. call option	Exercising/ exercised against	Number of securities	Exercise price per unit

(d)        Other dealings (including subscribing for new securities)

Class of relevant security	Nature of dealing e.g. subscription, conversion	Details	Price per unit (if applicable)

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?	NO

Date of disclosure:	16 October, 2018
Contact name:	Pauline Rogers
Telephone number*:	020 7645 9700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RETMMMMGFVFGRZM